Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-03
2005-05-03
Kunz, Gary (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S015800, C530S300000, C530S327000
Reexamination Certificate
active
06887844
ABSTRACT:
The invention provides novel compounds which are capable to stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM). Additionally, the invention relates to pharmaceutical compositions, medicaments and methods for treatment of normal, degenerated and damaged NCAM presenting cells.
REFERENCES:
Doherty et al. (Mar. 1995) “The Neural Cell Adhesion Molecule and Synaptic Plasticity.” J. Neurobiol. 26(3):437-446.*
Wells, 1990, Biochemistry 29:8509-8517.*
Ngo et al.. 1994, The Protein Folding Problem and Tertiary Structure Prediction. pp. 492-495.*
Bork. 2000, Genome Research 10:398-400.*
Skolnick et al., 2000, Trends in Biotech. 18(1): 34-39.*
Doerks et al., 1998, Trends in Genetics 14:248-250.*
Smith et al., 1997, Nature Biotechnology 15:1222-1223.*
Brenner, 1999, Trends in Genetics 15:123-133.*
Bork et al., 1996, Trends in Genetics 12:425-427.*
Andersson et al.; “Age-related changes in expression of the neural cell adhesion molecule in skeletal muscle: a comparative study of newborn, adult and aged rats”; Biochemical Journal 1993; 290: 641-648.
Beggs et al.; “NCAM140 Interacts with the Focal Adhesion Kinase p125fakand the SRC-related Tyrosine Kinase p59fyn”; Journal of Biological Chemistry 1997; 272, No. 13: 8310-8319.
Carenini et al.; “Absence of the myelin-associated glycoprotein (MAG) and the neural cell adhesion molecule (N-CAM) interferes with the maintenance, but not with the formation of peripheral myelin”; Cell and Tissue Research 1997; 287: 3-9.
Cremer et al.; “NCAM Is Essential for Axonal Growth and Fasciculation in the Hippocampus”; Molecular & Cellular Neurosciences 1997; 8: 323-335.
Cremer et al.; “Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning”; Nature 1994; 367: 455-459.
Daniloff et al.; “Altered Expression of Neuronal Cell Adhesion Molecules Induced by Nerve Injury and Repair”; Journal of Cell Biology 1986; 103: 929-945.
Daston et al.; “Spatially Restricted Increase in Polysialic Acid Enhances Corticospinal Axon Branching Related To Target Recognition and Innervation”; Journal of Neuroscience 1996; 16: 5488-5497.
Doherty et al.; “The vase exon downregulates the neurite growth-promoting activity of NCAM 140”; Nature 1992; 356: 791-793.
Doherty et al.; “Review CAM-FGF Receptor Interactions: A Model for Axonal Growth”; Molecular and Cellular Neuroscience 1996; 8: 99-111.
Doyle et al.; “Hippocampal NCAM180 Transiently Increases Sialylation During the Acquisition and Consolidation of a Passive Avoidance Response in the Adult Rat”; Journal of Neuroscience Research 1992; 31: 513-523.
Edelman et al.; “Place-dependent Cell Adhesion, Process Retraction, and Spatial Signaling in Neural Morphogenesis”; Cold Spring Harbor Symposia on Quantitative Biology, Cold Spring Harbor Laboratory Press, 1990: 303-318.
Fazeli et al.; “The role of cell adhesion molecules during the development and regeneration of the neuromuscular system”; Seminars in the Neurosciences 1996; 8: 367-377.
Fields et al.; “Neural cell Adhesion molecules in activity-dependent development and synaptic plasticity”; Trends in Neurosciences 1996; 19: 473-480.
Frei et al.; “Different Extracellular Domains of the Neural Cell Adhesion Molecule (N-CAM) Are Involved in Different Functions”; Journal of Cell Biology 1992; 118: 177-194.
Furka et al.; “General method for rapid synthesis of multicomponent peptide mixtures”; International Journal of Peptide and Protein Research 1991; 37: 487-493.
Gaardsvoll et al.; “Age-related changes in expression of neural cell adhesion molecule (NCAM) in heart: a comparative study of newborn, adult and aged rats”; European Journal of Cell Biology 1993; 61: 100-107.
Horstkorte et al.; “The Fourth Immuneoglobulin-like Domain of NCAM Contains a Carbohydrate Recognition Domain for Oligomannosidic Glycans Implicated in Association with L1 and Neurite Outgrowth”; The Journal of Cell Biology 1993; vol. 121, No. 6, 1409-1421.
Jucker et al.; “Transient upregulation of NCAM mRNA in astrocytes in response to entorhinal cortex lesions and ischemia”; Brain Research 1995; Molecular Brain Rese.: 149-156.
Kasper et al.; “Functional Characterization of NCAM Fibronectin Type III Domains: Demonstration of Modulatory Effects of the Proline-Rich Sequence Encoded by Alternatively Spliced Exons a and AAG”; Journal of Neuroscience Research 1996; 46: 173-186.
Kiselyov et al.; “The First Immunoglobulin-like Neural Cell Adhesion Molecule (NCAM) Domain Is Involved in Double-reciprocal Interaction with the Second Immunoglobulin-like NCAM Domain and in Heparin Binding”; Journal of Biological Chemistry 1997; 272: 10125-10134.
Knittel et al.; “Cell-Type-Specific Expression of Neural Cell Adhesion Molecule (N-CAM) in Ito Cells of Rat Liver, Up-Regulation during in Vitro Activation and in Hepatic Tissue Repair”; American Journal of Pathology 1996; 149: 449-462.
Krushel et al.; “Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation”; Proceedings of the National Academy Of Science of the United States of America 1998; 95: 2592-2596.
Lackie et al.; “Polysialic acid and N-CAM localisation in embryonic rat kidney: mesenchymal and epithelial elements show different patterns of expression”; Development 1990; 110: 933-947.
Lahrtz et al.; “Vase-Encoded Peptide Modifies NCAM-and L1-Mediated Neurite Outgrowth”; Journal of Neuroscience Research 1997; 50: 62-68.
Lam et al.; “A new type of synthetic peptide library for identifying ligand-binding activity”; Nature 1991; 354:82-84.
Lam et al.; “Streptavidin and Avidin Recognize Peptide Ligands with Different Motifs”; Immunomethods 1992; 1: 11-15.
Landsmesser et al.; “Polysialic Acid As a Regulator of Intramuscular Nerve Branching during Embryonic Development”; Neutrone 1990; 4-655-667.
Lüthl et al.; “Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM”; Nature 1994; 372:777-779.
Maar et al.; “Characterization of Microwell Cultures of Dissociated Brain Tissue for Studies of Cell-Cell Interactions”; Journal of Neuroscience Research 1997; 47: 163-172.
Massaro et al.; “N-CAM in cerebrospinal fluid: a marker of synaptic remodelling after acute phases of multiple sclerosis?”; Italian Jorunal of Neurological Sciences 1987; Suppl. 6:85-88.
Møller et al.; “NCAM in developing mouse gonads and ducts”; Anatomy and Embryology 1991; 184: 541-548.
Møller et al.; “Differential Expression of Neural Cell Adhesion Molecule and Cadherins in Pancreatic Islets, Glucagonomas, and Insulinomas”; Molecular Endocrinology 1992; 6: 1332-1342.
Nieke et al.; “Expression of the neural cell adhesion molecules L1 and N-CAM and their common carbohydrate epitope L2/HNK-1 during development and after transection of the mouse sciatic nerve”; Differentation 1985; 30: 141-151.
Olsen et al.; “The Ability to Re-Express Polysialylated NCAM In Soleus Muscle After Denervation is Reduced In Aged Rats Compared To Young Adult Rats”; Int J Devl Neuroscience 1995; 13: 97-104.
Ono et al.; “N-CAM Mutation Inhibits Tangential Neuronal Migration and Is Phenocopied by Enzymatic Removal of Polysialic Acid”; Neurone 1994; 13: 595-609.
Pollerberg et al.; “A Functional Role for the Middle Extracellular Region of the Neural Cell Adhesion Molecule (NCAM) in Axonal Fasciculation and Orientation”; Developmental Biology 1993; 156(2): 324-340.
Rabinowitz et al.; “Targeted mutation of Ncam to produce a secreted molecule results in a dominant embryonic lethality”; Proceedings
Berezin Vladimir
Bock Elisabeth
Holm Arne
Jensen Peter H.
Olsen Marianne
Cooer Iver P.
Kunz Gary
Nichols Christopher James
LandOfFree
NCAM binding compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NCAM binding compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NCAM binding compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3452957